- Q4 sales of $6.0
billion, up 0.1% YoY; adjusted sales of $5.8 billion with organic growth up 2.1%
YoY
- Q4 GAAP EPS from continuing operations of $1.33, up 17% YoY; adjusted EPS from
continuing operations of $1.68, down
2% YoY
- Full-year sales of $24.6
billion, down 0.1% YoY; adjusted sales of $23.6 billion with organic growth of 1.2%
YoY
- Full-year GAAP EPS from continuing operations of
$7.26; adjusted EPS from continuing
operations of $7.30, up
21% YoY
- Full-year operating cash flow of $1.8
billion with adjusted free cash flow of $4.9 billion
ST.
PAUL, Minn., Jan. 21,
2025 /PRNewswire/ -- 3M
(NYSE: MMM) today reported fourth-quarter and full-year
2024 results and provided its 2025 financial guidance.
"Our fourth quarter capped a year of strong results as we
returned to positive organic revenue growth in the full year," said
William Brown, 3M Chief Executive Officer. "I would like to
thank the 3M team for their strong
operational execution which helped us deliver double-digit earnings
growth and robust free cash flow while returning $3.8 billion to shareholders. We are carrying
this momentum forward and are confident in our ability to deliver
our 2025 guidance."
Fourth-Quarter Highlights:
|
|
|
|
|
Q4 2024
|
|
Q4 2023
|
|
|
|
|
GAAP EPS from
continuing operations (GAAP EPS)
|
|
$
1.33
|
|
$
1.14
|
|
|
|
|
Special
items:
|
|
|
|
|
|
|
|
|
Net costs for
significant litigation
|
|
(0.07)
|
|
0.36
|
|
|
|
|
(Increase) decrease in
value of Solventum ownership
|
|
0.24
|
|
—
|
|
|
|
|
Other special items,
net
|
|
0.18
|
|
0.20
|
|
|
|
|
Adjusted EPS from
continuing operations (Adjusted EPS)
|
|
$
1.68
|
|
$
1.70
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Memo:
|
|
|
|
|
|
|
|
|
GAAP operating income
margin
|
|
18.1 %
|
|
15.0 %
|
|
|
|
|
Adjusted operating
income margin
|
|
19.7 %
|
|
19.9 %
|
|
- GAAP EPS of $1.33 and operating
margin of 18.1%.
- Adjusted EPS of $1.68, down 2%
year-on-year.
- Adjusted operating income margin of 19.7%, a decrease of 0.2
percentage points year-on-year.
|
|
|
|
|
GAAP
|
|
Adjusted
(Non-GAAP)
|
|
|
|
|
Net sales
(Millions)
|
|
$6,010
|
|
$5,808
|
|
|
|
|
Sales
change
|
|
|
|
|
|
|
|
|
Total sales
|
|
0.1 %
|
|
2.2 %
|
|
|
|
|
Components of sales
change:
|
|
|
|
|
|
|
|
|
Organic
sales1
|
|
— %
|
|
2.1 %
|
|
|
|
|
Acquisitions/divestitures
|
|
0.9 %
|
|
0.9 %
|
|
|
|
|
Translation
|
|
(0.8) %
|
|
(0.8) %
|
|
|
|
|
Adjusted sales excludes
manufactured PFAS products.
|
|
|
|
|
1Above
adjusted organic sales increase includes a 70 basis point headwind
from product portfolio initiatives and exit of
certain small countries.
|
|
- Sales of $6.0 billion, up 0.1%
year-on-year with organic sales flat year-on-year.
- Adjusted sales of $5.8 billion,
up 2.2% year-on-year with adjusted organic sales up 2.1%
year-on-year.
- 3M returned $1.1 billion to shareholders via dividends and
share repurchases.
- Cash from operations of $1.8
billion.
- Adjusted free cash flow of $1.3
billion.
Full-Year Highlights:
|
|
|
|
|
Full Year
2024
|
|
Full Year
2023
|
|
|
|
|
GAAP earnings (loss)
per share from continuing operations
|
|
$
7.26
|
|
$
(15.17)
|
|
|
|
|
Special
items:
|
|
|
|
|
|
|
|
|
(Increase) decrease in
value of Solventum ownership
|
|
(2.83)
|
|
—
|
|
|
|
|
Net costs for
significant litigation
|
|
1.32
|
|
21.00
|
|
|
|
|
Pension risk transfer
charge
|
|
1.11
|
|
—
|
|
|
|
|
Other special items,
net
|
|
0.44
|
|
0.21
|
|
|
|
|
Adjusted earnings per
share (EPS) from continuing operations
|
|
$
7.30
|
|
$
6.04
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Memo:
|
|
|
|
|
|
|
|
|
GAAP operating income
(loss) margin
|
|
19.6 %
|
|
(43.4) %
|
|
|
|
|
Adjusted operating
income margin
|
|
21.4 %
|
|
18.6 %
|
|
- GAAP EPS of $7.26 and operating
margin of 19.6%.
- Adjusted EPS of $7.30, up 21%
year-on-year.
|
|
|
|
|
GAAP
|
|
Adjusted
(Non-GAAP)
|
|
|
|
|
Net sales
(Millions)
|
|
$24,575
|
|
$23,630
|
|
|
|
|
Sales
change
|
|
|
|
|
|
|
|
|
Total sales
|
|
(0.1) %
|
|
1.3 %
|
|
|
|
|
Components of sales
change:
|
|
|
|
|
|
|
|
|
Organic
sales2
|
|
(0.2) %
|
|
1.2 %
|
|
|
|
|
Acquisitions/divestitures
|
|
0.8 %
|
|
0.9 %
|
|
|
|
|
Translation
|
|
(0.7) %
|
|
(0.8) %
|
|
|
|
|
Adjusted sales excludes
manufactured PFAS products.
|
|
|
|
|
2Above
adjusted organic sales increase includes a 110 basis point headwind
from product portfolio initiatives
and exit of certain small countries.
|
|
- Sales of $24.6 billion, down 0.1
percent year-on-year with organic sales decline of 0.2 percent
year-on-year.
- Adjusted sales of $23.6 billion,
up 1.3 percent year-on-year with adjusted organic sales increase of
1.2 percent year-on-year.
- 3M returned $3.8 billion to shareholders via dividends and
share repurchases.
- Cash from operations of $1.8
billion, including $3.8
billion net after tax payments for costs of significant
litigation, primarily Public Water Systems and Combat Arms
Earplugs.
- Adjusted free cash flow of $4.9
billion.
This document includes reference to certain non-GAAP measures.
See the "Supplemental Financial Information Non-GAAP Measures"
section for applicable information.
Full-Year 2025 Guidance
3M provided the following
full-year 2025 expectations.
- Adjusted total sales growth3 in the range of 0.5 to
1.5 percent, reflecting adjusted organic sales3 growth
of 2 to 3 percent.
- Adjusted EPS3 in the range of $7.60 to $7.90.
- Adjusted operating cash flow3 of $5.2 to $5.3
billion, contributing to approximately 100 percent adjusted
free cash flow conversion3.
3As further discussed at 6 within the
"Supplemental Financial Information Non-GAAP Measures" sections,
3M cannot, without unreasonable
effort, forecast certain items required to develop meaningful
comparable GAAP financial measures and, therefore, does not provide
them on a forward-looking basis reflecting these items.
Conference Call
3M will conduct an investor
teleconference at 9 a.m. ET (8 a.m. CT) today. Investors
can access this conference via the following:
- Live webcast at https://investors.3M.com
- Webcast replay at
https://investors.3m.com/financials/quarterly-earnings
Consolidated Financial Statements and Supplemental Financial
Information Non-GAAP Measures
View the Financial Statement Information on 3M's website:
https://investors.3m.com/financials/quarterly-earnings
Forward-Looking Statements
This news release contains forward-looking statements. You
can identify these statements by the use of words such as "plan,"
"expect," "aim," "believe," "project," "target," "anticipate,"
"intend," "estimate," "will," "should," "could," "would,"
"forecast" and other words and terms of similar meaning.
Forward-looking statements are based on certain assumptions and
expectations of future events and trends that are subject to risks
and uncertainties. Actual future results and trends may differ
materially from historical results or those reflected in any such
forward-looking statements depending on a variety of factors. Among
the factors that could cause actual results to differ materially
are the following: (1) worldwide economic, political, regulatory,
international trade, geopolitical, capital markets and other
external conditions and other factors beyond the Company's control,
including inflation, recession, military conflicts, and natural and
other disasters or climate change affecting the operations of the
Company or its customers and suppliers; (2) foreign currency
exchange rates and fluctuations in those rates; (3) liabilities and
the outcome of contingencies related to certain fluorochemicals;
known as "PFAS," including liabilities related to claims, lawsuits,
and government regulatory proceedings concerning various
PFAS-related products and chemistries, as well as risks related to
the Company's plans to exit PFAS manufacturing and work to
discontinue use of PFAS across its product portfolio; (4) risks
related to the class-action settlement to resolve claims by public
water suppliers in the United
States regarding PFAS; (5) legal proceedings, including
significant developments that could occur in the legal and
regulatory proceedings described in the Company's reports on Form
10-K, 10-Q and 8-K (the "Reports"); (6) competitive conditions and
customer preferences; (7) the timing and market acceptance of new
product and service offerings; (8) the availability and cost of
purchased components, compounds, raw materials and energy due to
shortages, increased demand and wages, supply chain interruptions,
or natural or other disasters; (9) unanticipated problems or delays
with the phased implementation of a global enterprise resource
planning system, or security breaches and other disruptions to the
Company's information or operational technology infrastructure;
(10) the impact of acquisitions, strategic alliances, divestitures,
and other strategic events resulting from portfolio management
actions and other evolving business strategies; (11) operational
execution, including the extent to which the Company can realize
the benefits of planned productivity improvements, as well as the
impact of organizational restructuring activities; (12) financial
market risks that may affect the Company's funding obligations
under defined benefit pension and postretirement plans; (13) the
Company's credit ratings and its cost of capital; (14) tax-related
external conditions, including changes in tax rates, laws or
regulations; (15) matters relating to the spin-off of the Company's
Health Care business, including the risk that the expected benefits
will not be realized; the risk that the costs or dis-synergies will
exceed the anticipated amounts; potential impacts on the Company's
relationships with its customers, suppliers, employees, regulators
and other counterparties; the ability to realize the desired tax
treatment; the risk that any consents or approvals required will
not be obtained; risks under the agreements and obligations entered
into in connection with the spin-off, and (16) matters relating to
Combat Arms Earplugs ("CAE"), including those related to, the
August 2023 settlement that is
intended to resolve, to the fullest extent possible, all litigation
and alleged claims involving the CAE sold or
manufactured by the Company's subsidiary Aearo Technologies and
certain of its affiliates and/or the Company. A further description
of these factors is located in the Reports under "Cautionary Note
Concerning Factors That May Affect Future Results" and "Risk
Factors" in Part I, Items 1 and 1A (Annual Report) and in Part I,
Item 2 and Part II, Item 1A (Quarterly Reports). Changes in such
assumptions or factors could produce significantly different
results. The Company assumes no obligation to update any
forward-looking statements discussed herein as a result of new
information or future events or developments.
About 3M
3M (NYSE: MMM) believes science
helps create a brighter world for everyone. By unlocking the power
of people, ideas and science to reimagine what's possible, our
global team uniquely addresses the opportunities and challenges of
our customers, communities, and planet. Learn how we're working to
improve lives and make what's next at 3M.com/news.
Please note that the company announces material financial,
business and operational information using the 3M investor relations website, SEC filings, press
releases, public conference calls and webcasts. The company also
uses the 3M News Center and social
media to communicate with our customers and the public about the
company, products and services and other matters. It is possible
that the information 3M posts on the
News Center and social media could be deemed to be material
information. Therefore, the company encourages investors, the media
and others interested in 3M to review
the information posted on 3M's news center and the social media
channels such as @3M or @3MNews.
Contacts
3M
Investor
Contacts:
Diane Farrow,
612-202-2449
or
Eric Herron, 651-233-0043
Media Contact:
Sean Lynch,
slynch2@mmm.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/3m-reports-fourth-quarter-and-full-year-2024-results-initiates-full-year-2025-financial-guidance-302355783.html
SOURCE 3M Company